|
|
|
Insider
Information: |
Sing George L |
Relationship: |
Director |
City: |
Tarrytown |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
27,472 |
|
Indirect Shares
|
2,150 |
|
|
Direct
Value |
$27,060,469 |
|
|
Indirect Value
|
$2,117,793 |
|
|
Total
Shares |
29,622 |
|
|
Total
Value |
$29,178,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
34
|
Stock
price went up :
|
0
|
17
|
Stock
price went down : |
0
|
17
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
3.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-05-03 |
27,472 |
2024-05-03 |
2,150 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
100 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2014-02-14 |
4 |
OE |
$9.17 |
$137,550 |
D/D |
15,000 |
127,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2014-02-14 |
4 |
S |
$324.00 |
$4,860,000 |
D/D |
(15,000) |
112,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2014-02-21 |
4 |
OE |
$15.80 |
$237,000 |
D/D |
15,000 |
117,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2014-02-21 |
4 |
S |
$338.00 |
$5,085,000 |
D/D |
(15,000) |
112,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2015-02-20 |
4 |
OE |
$18.61 |
$279,150 |
D/D |
15,000 |
127,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2015-02-20 |
4 |
S |
$423.12 |
$6,346,800 |
D/D |
(15,000) |
112,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2015-05-27 |
4 |
S |
$515.00 |
$2,575,000 |
D/D |
(5,000) |
112,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2015-05-27 |
4 |
OE |
$19.69 |
$98,450 |
D/D |
5,000 |
117,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2015-11-18 |
4 |
S |
$580.00 |
$290,000 |
I/I |
(500) |
4,500 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2015-11-18 |
4 |
S |
$580.00 |
$1,740,000 |
D/D |
(3,000) |
112,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2015-11-18 |
4 |
OE |
$19.69 |
$59,070 |
D/D |
3,000 |
115,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2017-01-03 |
4 |
OE |
$19.69 |
$137,830 |
D/D |
7,000 |
119,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2018-01-02 |
4 |
OE |
$23.84 |
$357,600 |
D/D |
15,000 |
134,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2018-05-09 |
4 |
S |
$285.29 |
$1,997,030 |
D/D |
(7,000) |
127,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2018-05-10 |
4 |
S |
$285.00 |
$3,726,000 |
D/D |
(13,000) |
114,772 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
323 |
115,095 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-01-02 |
4 |
OE |
$24.41 |
$366,150 |
D/D |
15,000 |
130,095 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-01-02 |
4 |
AS |
$371.98 |
$5,579,700 |
D/D |
(15,000) |
115,095 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
320 |
115,415 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-02-26 |
4 |
S |
$460.00 |
$1,150,000 |
D/D |
(2,500) |
115,415 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-02-26 |
4 |
OE |
$33.42 |
$83,550 |
D/D |
2,500 |
117,915 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-02-26 |
4 |
S |
$450.00 |
$1,086,800 |
I/I |
(2,400) |
9,000 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-05-11 |
4 |
S |
$575.00 |
$488,750 |
I/I |
(850) |
8,700 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-05-13 |
4 |
OE |
$33.42 |
$167,100 |
D/D |
5,000 |
120,415 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-05-13 |
4 |
S |
$580.00 |
$2,900,000 |
D/D |
(5,000) |
115,415 |
0 |
% |
|
100 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|